INOVIO's INO-5401 in Combination with PD-1 Inhibitor Libtayo(R...
PLYMOUTH MEETING, Pennsylvania, May 14, 2020 /PRNewswire-AsiaNet/ -- - Results Will Be Presented at the American Society of Clinical Oncology (ASCO) 2020 Annual MeetingINOVIO (NASDAQ: INO) today announced that 85 percent (44 out of 52) of patients newly diagnosed with the deadly brain cancer glioblastoma multif...
Authors: LATEST ASIANET NEWS RELEASES